4//SEC Filing
Tubridy Karen L 4
Accession 0001562180-20-001934
CIK 0001517022other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 7:26 PM ET
Size
9.4 KB
Accession
0001562180-20-001934
Insider Transaction Report
Form 4
Tubridy Karen L
SVP, Chief Development Officer
Transactions
- Award
Common Stock
2020-02-28+30,000→ 88,133 total - Award
Stock Option (Right to buy)
2020-02-28+85,000→ 85,000 totalExercise: $8.87Exp: 2030-02-28→ Common Stock (85,000 underlying) - Sale
Common Stock
2020-02-28$8.70/sh−3,454$30,050→ 84,679 total
Footnotes (4)
- [F1]The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date.
- [F2]Includes 1,364 shares of the Issuer's common stock purchased on June 28, 2019 and 1,445 shares of the Issuer's common stock purchased on December 31, 2019, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan.
- [F3]This sale was made to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2019.
- [F4]The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001589888
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 7:26 PM ET
- Size
- 9.4 KB